Literature DB >> 9549249

SSRI discontinuation syndrome related to fluvoxamine.

F Benazzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9549249      PMCID： PMC1188907     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  3 in total

1.  Venlafaxine withdrawal symptoms.

Authors:  F Benazzi
Journal:  Can J Psychiatry       Date:  1996-09       Impact factor: 4.356

Review 2.  Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.

Authors:  A F Schatzberg; P Haddad; E M Kaplan; M Lejoyeux; J F Rosenbaum; A H Young; J Zajecka
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

3.  Serotonin reuptake inhibitor withdrawal.

Authors:  N J Coupland; C J Bell; J P Potokar
Journal:  J Clin Psychopharmacol       Date:  1996-10       Impact factor: 3.153
  3 in total
  1 in total

Review 1.  Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

Authors:  D P Figgitt; K J McClellan
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.